Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

INTRODUCTION: As chimeric antigen receptor T-cell therapies are becoming increasingly available in the armamentarium of the hematologist, there is an emerging need to monitor post-marketing safety. OBJECTIVE: We aimed to better characterize their safety profile by focusing on cytokine release syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusaroli, Michele, Isgrò, Valentina, Cutroneo, Paola Maria, Ferrajolo, Carmen, Cirillo, Valentina, Del Bufalo, Francesca, Raschi, Emanuel, Poluzzi, Elisabetta, Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360149/
https://www.ncbi.nlm.nih.gov/pubmed/35829913
http://dx.doi.org/10.1007/s40264-022-01194-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360149/
https://www.ncbi.nlm.nih.gov/pubmed/35829913
http://dx.doi.org/10.1007/s40264-022-01194-z

Ejemplares similares